Clinical characteristics of the 64 diabetic patients with fasting plasma glucose levels <170 mg/dl and the same number of nondiabetic patients
| . | Diabetic . | Nondiabetic . |
|---|---|---|
| n | 64 | 64 |
| Age (years) | 59.8 ± 10.6 | 54.1 ± 10.8* |
| Sex (male/female) | 35/32 | 31/30 |
| BMI (kg/m2) | 24.8 ± 0.6 | 26.2 ± 0.77 |
| L/S ratio | 1.063 ± 0.034 | 1.039 ± 0.036 |
| VFA (cm2) | 117 ± 11.7 | 114 ± 7.59 |
| SFA (cm2) | 180 ± 12.9 | 180 ± 10.9 |
| Ferritin (ng/ml) | 167.1 ± 17.5 | 183.9 ± 24.6 |
| Glucose (mg/dl) | 129.2 ± 2.86 | 105.2 ± 1.43† |
| Insulin (μU/ml) | 9.10 ± 0.861 | 9.34 ± 0.746 |
| HOMA-IR | 2.893 ± 0.233 | 2.100 ± 0.113† |
| A1C (%) | 6.87 ± 0.128 | 5.09 ± 0.39† |
| C-reactive protein (mg/dl) | 0.099 ± 0.014 | 0.103 ± 0.014 |
| AST (IU/l) | 30.5 ± 3.08 | 31.6 ± 2.37 |
| ALT (IU/l) | 37.4 ± 5.09 | 45.6 ± 5.40 |
| Smoking (%) | 20.7 | 12.8 |
| . | Diabetic . | Nondiabetic . |
|---|---|---|
| n | 64 | 64 |
| Age (years) | 59.8 ± 10.6 | 54.1 ± 10.8* |
| Sex (male/female) | 35/32 | 31/30 |
| BMI (kg/m2) | 24.8 ± 0.6 | 26.2 ± 0.77 |
| L/S ratio | 1.063 ± 0.034 | 1.039 ± 0.036 |
| VFA (cm2) | 117 ± 11.7 | 114 ± 7.59 |
| SFA (cm2) | 180 ± 12.9 | 180 ± 10.9 |
| Ferritin (ng/ml) | 167.1 ± 17.5 | 183.9 ± 24.6 |
| Glucose (mg/dl) | 129.2 ± 2.86 | 105.2 ± 1.43† |
| Insulin (μU/ml) | 9.10 ± 0.861 | 9.34 ± 0.746 |
| HOMA-IR | 2.893 ± 0.233 | 2.100 ± 0.113† |
| A1C (%) | 6.87 ± 0.128 | 5.09 ± 0.39† |
| C-reactive protein (mg/dl) | 0.099 ± 0.014 | 0.103 ± 0.014 |
| AST (IU/l) | 30.5 ± 3.08 | 31.6 ± 2.37 |
| ALT (IU/l) | 37.4 ± 5.09 | 45.6 ± 5.40 |
| Smoking (%) | 20.7 | 12.8 |
Data are means ± SE.
P < 0.05;
P < 0.01 diabetic vs. nondiabetic.